Central Pacific Bank - Trust Division’s Edwards Lifesciences EW Stock Holding History

Central Pacific Bank - Trust Division’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-9,088	Closed	-$822K	–	880
2026 Q2	$822K	Hold	9,088	–	–	0.08%	230
2026 Q1	$728K	Hold	9,088	–	–	0.09%	224
2025 Q4	$775K	Buy	+9,088	New	+$746K	0.1%	226
2024 Q4	–	Sell	-7,736	Closed	-$510K	–	898
2024 Q3	$510K	Sell	7,736 -4,382	-36%	-$318K	0.06%	275
2024 Q2	$1.12M	Sell	12,118 -145	-1%	-$12.8K	0.13%	163
2024 Q1	$1.16M	Buy	+12,263	New	+$1.03M	0.14%	162

Other funds holding EW

Jacobs & Co San Francisco, California $1.16B AUM 34.03% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $514M AUM 11.69% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return

BRCM

Bright Rock Capital Management Hanover, Massachusetts $529M AUM 8.66% 1-Year Est. Return

IWA

Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.48B AUM 34.49% 1-Year Est. Return

ACM

Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return

WPC

Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Central Pacific Bank - Trust Division's EW Position: Q3 2026 in Review

Central Pacific Bank - Trust Division sold out of Edwards Lifesciences (EW) in Q3 2026, closing a stake of 9,088 shares — an estimated $822K sold.

Central Pacific Bank - Trust Division first reported a position in EW in Q1 2024 and held it in 6 quarters. The position peaked at $1.16M in Q1 2024. 51 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Central Pacific Bank - Trust Division reported no remaining Edwards Lifesciences position as of Q3 2026 after selling out during the quarter.
Central Pacific Bank - Trust Division sold 9,088 Edwards Lifesciences shares in Q3 2026, an estimated $822K.
Central Pacific Bank - Trust Division first reported a position in Edwards Lifesciences in Q1 2024 and held it in 6 quarters.
Central Pacific Bank - Trust Division's Edwards Lifesciences position peaked at $1.16M in Q1 2024.
51 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q3 2026, filed 6 Oct 2026.